NEW YORK--(BUSINESS WIRE)--Sugarbreak, the first all natural, complete solution to help reduce sugar consumption and promote healthy blood sugar management, has raised nearly $3 million in its latest round of funding. This round included exclusively mission-focused investors: SKAGEN Conscience Capital (Method), Bronze (LendUp, Promise, Virta Health), BBG Ventures (LOLA, The Wing, Zola) and Sorven Capital. Funding will be utilized towards expanding availability and product development as the brand looks to innovate and add additional offerings in early 2021.
“We deliberately only included mission-focused institutional investors in this round, as we are a public benefit corporation that is focused on reducing sugar consumption and improving blood sugar health,” said Scarlett Leung, Co-Founder and CEO of Sugarbreak. “Skagen Conscience Capital is a values driven family office that seeks to invest for positive impact, BBG Ventures is a VC fund leading investments in female-founded startups addressing fundamental issues in the lives of today’s more diverse, conscious and connected consumer, and Bronze invests in businesses that transform disparity into prosperity for Eastside communities.”
Sugarbreak launched in September of 2020 and was founded by veteran entrepreneurs including Leung (Trellis Health), Adam Lowry (Ripple Foods & Method Products), Kyle Heller (VMG Creative) and Luke Raymond (VMG Creative), who are leveraging their decades of experience to provide an all natural, comprehensive solution for blood sugar management conveniently available direct-to-consumer, without a doctor’s prescription. The brand launched with three introductory products, Resist, Stabilize, and Reduce, which were created by harnessing the power of plants and nature with minimal side effects.
“Sugarbreak stood out to us because they are female-founded and addressing a huge health issue the 99% is facing in America — high blood sugar,” said Nisha Dua, General Partner and Co-Founder of BBG Ventures. “Living a healthy lifestyle is increasingly the only health factor consumers can control during these uncertain times and Sugarbreak is a natural, but backed by science offering that allows people to be proactive about their own healthcare without turning to pharmaceuticals.”
“We only invest when a company’s product or service drives positive impact. Sugarbreak is addressing a monumental health crisis with diabetes and obesity, that was only highlighted further by the COVID-19 pandemic,” said Stephen DeBerry from Bronze. “Marginalized communities, Eastside communities, are disproportionately affected by diabetes and COVID-19, so investing in Sugarbreak’s mission to offer an affordable, accessible healthcare option was a no-brainer.”
Sugarbreak is the first-ever, all natural, complete solution for the reduction of sugar consumption and healthy blood sugar management. The comprehensive system offers proprietary formulations of scientifically-proven, all natural herbal ingredients backed by over 20 ingredient clinical studies. Sugarbreak's three introductory products, Resist, Stabilize, and Reduce, were created by harnessing the power of plants and nature, with no known side effects based on usage to date. Sugarbreak is a Public Benefit Corporation and was created to help people reduce their sugar consumption and maintain healthy blood sugar as part of a healthy lifestyle. Sugarbreak is supported by notable medical professionals including Dr. Tom Hildebrandt, Chief of the Division of Eating & Weight Disorders (Center of Excellence) at Mount Sinai, Dr. Robert Graham, MD, MPH, ABOIM, FACP and Co-Founder of FRESH Med, and Dr. Priscilla Pemu, MD, who assists diabetics in marginalized communities through her work at Morehouse School of Medicine. Sugarbreak products are available now for purchase on Sugarbreak.com and Amazon. You can follow along on Instagram at @takeasugarbreak and Facebook at facebook.com/takeasugarbreak.